<i>Strongyloides</i> Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids
Jani M. Kim, Geetha Sivasubramanian
Abstract
Widespread use of corticosteroids for COVID-19 treatment has led to Strongyloides reactivation and severe disease in patients from endemic areas. We describe a US patient with COVID-19 and Strongyloides hyperinfection syndrome and review other reported cases. Our findings highlight the need for Strongyloides screening and treatment in high-risk populations.
Topics & Concepts
StrongyloidesStrongyloides stercoralisStrongyloidiasisCoronavirus disease 2019 (COVID-19)MedicineImmunologyDiseaseIntensive care medicineInternal medicineHelminthsInfectious disease (medical specialty)Parasites and Host InteractionsAmoebic Infections and Treatments